03/10/2025
8:20 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025
8:21 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
03/03/2025
5:40 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-4/A | |
02/27/2025
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/25/2025
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/25/2025
7:02 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
02/14/2025
4:08 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:43 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
02/10/2025
6:57 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
02/10/2025
6:54 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2025
5:45 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
Get the Latest News and Ratings for NLSPW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NLS Pharmaceutics and its competitors with MarketBeat's FREE daily newsletter. |
01/31/2025
6:47 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025
6:51 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
01/30/2025
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025
9:46 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
01/28/2025
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2025
4:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/16/2025
8:20 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025
8:22 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
01/14/2025
3:27 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025
7:04 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2025
7:14 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
01/07/2025
3:30 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:52 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024
7:54 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
12/30/2024
5:13 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions | |
12/23/2024
3:04 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
3:23 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K/A | |
12/19/2024
7:30 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024
7:32 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
12/17/2024
3:30 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
7:30 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
7:32 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
12/10/2024
7:30 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K/A | |
12/03/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024
11:15 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form EFFECT | |
11/21/2024
3:01 PM | Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G/A | |
11/18/2024
7:30 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024
4:00 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
6:27 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G/A | |
11/08/2024
3:00 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
11/05/2024
3:30 PM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
11/05/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
6:39 PM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
11/04/2024
5:20 PM | Grisard Felix (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G/A | |
11/04/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
7:02 AM | NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form 425 | |
10/28/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024
3:00 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
10/22/2024
3:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
4:19 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/18/2024
3:31 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
12:24 PM | ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G | |
10/15/2024
8:09 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
7:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
6:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024
3:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
7:13 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2024
3:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
4:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024
3:01 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
08/26/2024
3:40 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
3:30 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
8:16 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/01/2024
7:26 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 424B5 | |
07/01/2024
7:09 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
3:54 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
11:15 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form EFFECT | |
06/25/2024
3:31 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
8:28 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
8:13 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
4:25 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024
8:10 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
4:16 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
3:11 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
6:37 PM | Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
| Form SC 13G | |
03/22/2024
9:24 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 424B5 | |
03/21/2024
4:14 PM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
11:58 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
8:06 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
8:00 AM | NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
